Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology

  • A.R. Parrish
  • K. Sallam
  • D.W. Nyman
  • J. Orozco
  • A.E. Cress
  • B.L. Dalkin
  • R.B. Nagle
  • A.J. Gandolfi


Due to the complex morphology of the prostate, it was hypothesized that precision-cut tissue slices from human prostate would provide a unique in vitro model. Precision-cut slices were generated from zones of human prostate and their viability was assessed under conditions of different media for up to 120 h. Slices were also exposed to several concentrations of CdCl2, which was used as a model toxicant. Maintenance of both stromal and epithelial cells was noted; however, there was a gradual loss of luminal epithelial cells when the medium was not supplemented with dihydrotestosterone (DHT). Minimal leakage of lactate dehydrogenase occurred throughout the incubation. Prostate-specific antigen (PSA) was detected in the medium at all time points, although the rates of secretion fell over time. There was a loss of PSA-positive cells when the medium was not supplemented with DHT, consistent with a loss of luminal cells, whereas PSA-positive cells were maintained in the DHT-supplemented media. A proliferation of basal cells was observed in the presence of media containing 10% fetal bovine serum. Exposure of slices to CdCl2 demonstrated a dose-response effect ranging from proliferation to complete cellular necrosis. Given the retention of stromal-epithelial interactions and the use of acquired human tissue, prostate slices represent a unique in vitro model for investigating human prostate pathobiology.

prostate dynamic organ culture system peripheral transitional stromal–epithelial 


  1. Achanzar WE, Bhalchandra AD, Liu J, Duader ST, Webber MM, Waalkes MP. Cadmium-induced malignant transfor-mation of human prostate epithelial cells. Cancer Res. 2001; 61:455–8.PubMedGoogle Scholar
  2. Bonkhoff H, Remberger K. Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat. 1993:422:35–8.CrossRefGoogle Scholar
  3. Chodak GW, Kranc DM, Puy LA, Takeda H, Johnson K, Chang C. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neo-plastic human prostate. JUrol. 1992:147:798–803.Google Scholar
  4. Cunha GR. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer. 1994:74:1030–44.PubMedCrossRefGoogle Scholar
  5. Cunha GR, Donjacour AA, Cooke PS, et al. The endocrinology and developmental biology of the prostate. [Review]. Endocr Rev. 1987:8:338–62.PubMedCrossRefGoogle Scholar
  6. Cunha GR, Hayward SW, Dahiya R, Foster BA. Smooth muscle-epithelial interactions in normal and neoplastic prostate development. Acta Anat. 1996:155:63–72.PubMedCrossRefGoogle Scholar
  7. Dube JY, Chapdelaine P, Tremblay RR. Effect of testicular hormones on synthesisi of soluble proteins by dog prostate slices. Can J Biochem Cell Biol. 1983;61(7):756–63.PubMedCrossRefGoogle Scholar
  8. English HF, Santen RJ, Isaacs JT. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen with-drawal and replacement. Prostate. 1987:11:229–42.PubMedGoogle Scholar
  9. Farnsworth WE. Activities of the androgen-responsive receptor of the prostatic plasma membrane. Invest Urol. 1977:15(1): 75–7.PubMedGoogle Scholar
  10. Fisher RL, Nau H, Gandolfi AJ, Putnam CW, Brendel K. Valproic acid hepatotoxicity in human liver slices. Drug ChemToxicol. 1991a;14:375–94.Google Scholar
  11. Fisher RL, Hanziik RP, Gandolfi AJ, Brendel K. Toxicity of ortho-substituted bromobenzenes in rat liver slices: a com-parison to isolated hepatocytes and the whole animal. In VitroToxicol. 1991b;4:173–86.Google Scholar
  12. Fisher RL, Nau H, Gandolfi AJ, Brendel K. Toxicity of valproic acid in liver slices from Sprague-Dawley rats and domestic pigs. Toxicol InVitro. 1991c;5:201–5.CrossRefGoogle Scholar
  13. Geller J, Sionit LR, Connors K, Hoffinan RM. Measurement of androgen receptor sensitivity in the human prostate in vitro, three-dimensional histoculture. Prostate. 1992:21:269–78.PubMedGoogle Scholar
  14. Geller J, Partido C, Sionit L, et al. Comparison of androgen-independent growth and androgen-dependent growth in BPH and cancer tissue from the same radical prostatec-tomies in sponge-gel matrix histoculture. Prostate. 1997:31: 250–4.PubMedCrossRefGoogle Scholar
  15. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins: distribution of filament proteins in normal human tissues. Am J Pathol. 1984:114:309–21.PubMedGoogle Scholar
  16. Greenberg NM, DeMayo F, Finegold MJ, et al. Prostate cancer in a transgenic mouse. Proc Nati Acad Sci USA. 1995:92: 3439–3.CrossRefGoogle Scholar
  17. Hampton JA, Selman SH. Mechanisms of cell killing in photodynamic therapy using a novel in vivo drug/in vitro light culture system. Photochem Photobiol. 1992;56(2):235–42.PubMedGoogle Scholar
  18. Hayward SW, Rosen MA, Cunha GR. Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol. 1997;79(Supplement 2):18–26.PubMedGoogle Scholar
  19. Hairamatsu M, Kashimata M, Minami N, Sato A, Murayama M. Androgenic regulation of epidermal growth factor in the mouseventral prostate. Biochemint. 1998:17:311–7.Google Scholar
  20. Howat AJ, Mills PM, Lyons TJ, Stephenson TJ. Absence of S-100 proteins in prostatic glands. Histopathology. 1988;13: 468–70.PubMedGoogle Scholar
  21. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppi. 1989:2:33–50.Google Scholar
  22. Kasper S, Sheppard PC, Yan Y, et al. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest. 1998:78:319–33.PubMedGoogle Scholar
  23. Koenig H, Lu CY, Bakat R. Lysosomal enzyme secretion in rat ventral prostate. Acta Biol Med Germ. 1977:36 (11–12): 1653–9.PubMedGoogle Scholar
  24. Leav I, McNeal JE, Kwan PW, Komminoth P, Merk FB. Androgen receptor expression in prostatic dysplasia (pro-static intraepithelial neoplasia) in the human prostate: an immunohistochemical and 171 situ hybridization study. Prostate. 1996:29:137–45.PubMedGoogle Scholar
  25. Leong AS, Gilham P, Milos J. Cytokeratin and vimentin intermediate filament proteins in benign and neoplastic prostatic epithelium. Histopathology. 1988:13:435–42.PubMedGoogle Scholar
  26. Maitland NJ, Macintosh CA, Hall J, Sharrard M, Quinn G, Lang S. In vitro models to study cellular differentiation and function in human prostate cancers. Radiat Res. 2001:155: 133–2.PubMedCrossRefGoogle Scholar
  27. McCandless JR, Cress AE, Rabinovitz I, et al. A human xenograft model for testing early events of epithelial neo-plastic invasion. Int J Oncol. 1997:10:279–85.Google Scholar
  28. McNeal JE. Origin and development of carcinoma in the prostate. Cancer, 1969;23(l):24–34.PubMedCrossRefGoogle Scholar
  29. McNeal JE. Normal histology of the prostate. Am J Surg Pathol. 1988:12:619–33.PubMedGoogle Scholar
  30. Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR. The national cancer data base report on prostate carcinoma after the peak in incidence rates in the U.S. Cancer. 1998; 83:1679–84.PubMedCrossRefGoogle Scholar
  31. Montironi R, Bostwick DG, Bonkhoff H, et al. Origins of prostate cancer. Cancer. 1996;78(2):362–5.PubMedCrossRefGoogle Scholar
  32. Olbina G, Miljkovic D, Hoffman RM, Geller J. New sensitive discovery histoculture model for growth-inhibition studies in prostate cancer and BPH. Prostate. 1998:37:126–9.PubMedCrossRefGoogle Scholar
  33. Parrish AR, Shipp NG, Spall RD, et al. Organ culture of rat myocardial slices: an alternative 171 vitro tool in organ-specific toxicology. Toxicol Methods. 1992:2:101–11.Google Scholar
  34. Parrish AR, Gandolfi AJ, Brendel K. Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci. 1995:57:1887–901.PubMedCrossRefGoogle Scholar
  35. Pretlow TG, Yang B, Pretlow TP. Organ culture of benign, aging and hyperplastic human prostate. Microsc Res Tech. 1995:30:271–81.PubMedCrossRefGoogle Scholar
  36. Ruegg CE, Gandolfi AJ, Nagle RB, Brendel K. Differential patterns of injury to the proximal tubule of renal cortical slices following 171 vitro exposure to mercuric chloride, potassium dichromate, or hypoxic conditions. Toxicol Appi Pharmacol. 1987:90:261–73.CrossRefGoogle Scholar
  37. Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, et al. Androgen receptor status in localized and locally progres-sive hormone refractory human prostate cancer. Am J Pathol. 1994:144:735–46.PubMedGoogle Scholar
  38. Stonington OG, Hemmingsen H. Culture of cells as a mono-layer derived from the epithelium of the human prostate: a new cell growth technique. J Urol. 1971:106:393–400.PubMedGoogle Scholar
  39. Varani J, Dame MK, Wojno K, Schuger L, Johnson KJ. Characteristics of nonmalignant and malignant human prostate in organ culture. Lab Invest. 1999;79(6):723–31.PubMedGoogle Scholar
  40. Wolfgang GHI, Gandolfi AJ, Stevens JL, Brendel K. W-Acetyl-S(1,2-dichlorovinyl)-L-cysteine produces a similar toxicity to S-(l, 2-dichlorovinyD-L-cysteine in rabbit renal slices: differential transport and metabolism. Toxicol Appi Pharmacol. 1989:101:205–19.CrossRefGoogle Scholar
  41. Ye J, Wang S, Barger M, Castronova V, Shi X. Activation of androgen response element by cadmium: a potential me-chanism of a carcinogenic effect of cadmium in the prostate. J Environ Pathol Toxicol Oncol. 2000;19(3):275–80.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • A.R. Parrish
    • 1
  • K. Sallam
    • 2
  • D.W. Nyman
    • 1
  • J. Orozco
    • 1
  • A.E. Cress
    • 2
  • B.L. Dalkin
    • 3
  • R.B. Nagle
    • 2
  • A.J. Gandolfi
    • 1
  1. 1.Department of Medical PharmacologyTexas A&M UniversityCollege StationUSA
  2. 2.Department of Pathology, College of MedicineUniversity of ArizonaTucsonUSA
  3. 3.Department of Surgery, College of MedicineUniversity of ArizonaTucsonUSA

Personalised recommendations